OTC: ACXIF 21.95%
Underperform Recommendation Issued On ACXIF By RBC Capital
NASDAQ: NGNE 31.15%
Neurogene Shares Rally on FDA Breakthrough Therapy Designation for Rett Syndrome Therapy
NASDAQ: PRAA 32.17%
PRA Group (PRAA) Q4 2025 Earnings Call Transcript
OTC: DBLVF 24.07%
Top 5 Canadian Mining Stocks This Week: Adex Mining Shines with 171 Percent Gain
NYSE: BATL 21.08%
Halftime Market Summary: Stocks to Watch before Super Bowl Weekend
OTC: GHVNF 21.76%
Top 5 Canadian Mining Stocks This Week: Euro Manganese Gains 134 Percent
OTC: ACXIF 31.15%
OTC: NGNE 31.15%
OTC: PRAA 31.15%
OTC: DBLVF 31.15%
OTC: BATL 31.15%
